News

Q&A: Global sourcing for optimized cost and supply in clinical trials

Q&A: Global sourcing for optimized cost and supply in clinical trials

Based on our experience of implementing comparator sourcing strategy to meet studies’ increasing complexity, Oximio held a webinar to explore this topic further and provide actionable insight for our participants. Below is a short summary of the questions asked by our...

Clinical trial market report for Serbia

Clinical trial market report for Serbia

The number of clinical trials starting in Serbia is returning to pre-pandemic levels, but the context in which these studies are operating has changed. The impact of COVID-19 demonstrated the limitations of the direct-to-site logistics model, when supply chains were...

The logistics of extending the footprint of advanced therapy trials

The logistics of extending the footprint of advanced therapy trials

Cell and gene therapy innovators are scaling up and out to reach more patients. Clinical Trials Arena spoke to the team at Oximio (formerly the SMO Group) to discuss market developments. Most advanced therapy medicinal products (ATMPs, also known as cell and gene...

Global HR Digitalization at Oximio

Global HR Digitalization at Oximio

Over the past two years, Oximio’s operations have been affected by a combination of two factors: organic growth and geographic expansion. Significant organizational expansion has necessitated a comprehensive reconstruction of the human resources area – as...

Seven trends and market changes affecting clinical trials in 2021

Seven trends and market changes affecting clinical trials in 2021

The last 12 months were full of challenges for trial sponsors and the clinical trials market saw dynamic change when the Covid-19 pandemic introduced new logistical problems that had to be confronted and solved rapidly. Now, as the dust begins to settle,...

Oximio’s breath of fresh air

Oximio’s breath of fresh air

Transformation is an overused word in the modern business lexicon, so it’s refreshing to hear a business leader, in the midst of what many would consider a legitimate excuse to use the T word, talk instead about continuity and stability....

Oximio announces new Chief Operating Officer

Oximio announces new Chief Operating Officer

HUNTINGDON, Cambridgeshire, United Kingdom – 23 March 2021 – Clinical trial services provider, Oximio announced today that Peter Szabados has been appointed as the Chief Operating Officer (COO), joining the leadership team to enhance the client-focused operation....